FrancophonIA/ELRC3.0 huggingface dataset:
English: The affinity of antibodies against the HA1 domain of the H5 HA in the H5N1 P/LAIV-primed groups was significantly higher than the 2dose inactivated vaccine group, which correlated with cross-clade H5N1 neutralisation.
Croatian: Afinitet antitijela za domenu HA1 unutar H5 HA u ispitanika primarno cijepljenih P/LAIV H5N1 cjepivom bio je značajno veći nego u skupini ispitanika cijepljenih s dvije doze inaktiviranog cjepiva, što je bilo u korelaciji s križnom neutralizacijom s obzirom na podlinije H5N1.
English: In a study with the seasonal trivalent live attenuated influenza vaccine (T/LAIV), an increased incidence of medically significant wheezing was seen in children 12-23 months of age (see section
Croatian: U ispitivanju sezonskog trovalentnog živog atenuiranog cjepiva protiv influence (T/LAIV) u djece u dobi od 12 do 23 mjeseca zamijećena je povišena incidencija klinički značajnog piskanja (vidjeti dio 4.8).
English: Pandemic influenza vaccine H5N1 AstraZeneca vaccine virus is grown in chicken eggs.
Croatian: Virus pandemijskog cjepiva protiv influence H5N1 AstraZeneca uzgojen je u kokošjim jajima.
English: Days are counted relative to the only P/IIV dose for Groups 1-4 and after the first of 2 P/IIV doses for Group 5.
Croatian: Dani su brojani u odnosu na jedinu dozu cjepiva P/IIV za Skupine 1-4 i nakon prve od dvije doze cjepiva P/IIV za Skupinu 5. Serološki odgovor definiran kao ≥4-struko povećanje titra antitijela (≥ 1:20).
English: Antibody response developed rapidly in P/LAIV H5N1-primed subjects.
Croatian: Odgovor antitijela se brzo razvio u ispitanika primarno cijepljenih cjepivom P/LAIV H5N1.
English: .......................................................................................................per 0.2 ml dose
Croatian: .......................................................................................................po dozi od 0,2 ml
English: You can breathe normally while you are given Pandemic influenza vaccine H5N1 AstraZeneca.
Croatian: Možete normalno disati dok primate Pandemijsko cjepivo protiv influence H5N1 AstraZeneca.
English: What Pandemic influenza vaccine H5N1 AstraZeneca is and what it is used for What you need to know before you are given Pandemic influenza vaccine H5N1 AstraZeneca How Pandemic influenza vaccine H5N1 AstraZeneca is given Possible side effects
Croatian: Što je Pandemijsko cjepivo protiv influence H5N1 AstraZeneca i za što se koristi Što morate znati prije nego primite Pandemijsko cjepivo protiv influence H5N1 AstraZeneca
English: Improved efficacy (95% CI) matched strains
Croatian: Poboljšana djelotvornost (95% CI) podudarni sojevi
English: There have been reports of administration of twice the recommended dose of the seasonal vaccine Fluenz Tetra and the seasonal trivalent influenza vaccine live, intranasal (T/LAIV) in the post-marketing setting.
Croatian: Nakon stavljanja u promet, zabilježena je primjena dvostruke preporučene doze sezonskog cjepiva Fluenz Tetra i intranazalnog sezonskog trovalentnog živog atenuiranog cjepiva protiv influence.
English: • Refer to the Pandemic influenza vaccine H5N1 AstraZeneca administration diagram (Figure 1) for step-by-step administration instructions.
Croatian: • Pogledajte dijagram primjene Pandemijskog cjepiva protiv influence H5N1 AstraZeneca (slika 1) za upute o primjeni korak-po-korak.
English: Other medicines, other vaccines and Pandemic influenza vaccine H5N1 AstraZeneca Tell your doctor, nurse or pharmacist if the person being vaccinated is taking, has recently taken or might take any other medicines, including medicines that do not require a prescription.
Croatian: Obavijestite svog liječnika, medicinsku sestru ili ljekarnika ukoliko osoba koju se cijepi uzima, nedavno je uzela ili bi mogla uzeti bilo koje druge lijekove, uključujući i lijekove koji se ne izdaju na recept.
English: Corresponding rates for infants and toddlers 12-23 months of age were 5.4% and 3.6% for T/LAIV and injectable influenza vaccine, respectively.
Croatian: Odgovarajuće stope za dojenčad i malu djecu u dobi od 12 do 23 mjeseca bile su 5,4% za T/LAIV odnosno 3,6% za cjepivo protiv influence koje se injicira.
English: - If you have any further questions, ask your doctor, nurse or pharmacist.
Croatian: - Ako imate dodatnih pitanja, obratite se liječniku, ljekarniku ili medicinskoj sestri.
English: No data exist regarding the possible effects of Pandemic influenza vaccine H5N1 AstraZeneca on male and female fertility.
Croatian: Ne postoje podaci o mogućim učincima Pandemijskog cjepiva protiv influence H5N AstraZeneca na mušku i žensku plodnost.
English: Pandemic influenza vaccine H5N1 AstraZeneca has no or negligible influence on the ability to drive and use machines.
Croatian: Pandemijsko cjepivo protiv influence H5N1 AstraZeneca ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: How to store Pandemic influenza vaccine H5N1 AstraZeneca Contents of the pack and other information
Croatian: Kako čuvati Pandemijsko cjepivo protiv influence H5N1 AstraZeneca Sadržaj pakiranja i druge informacije
English: After 1 or 2 doses of 10 TCID50 vaccine, HAI and IgA seroresponses were each detected in 10% and 52% of subjects and nasal IgA responses were detected in 19% of subjects.
Croatian: TCID50, HAI i IgA serološki odgovori zabilježeni su u 10% ispitanika dok je nakon 2 doze zabilježen u 52% ispitanika, a nazalni IgA odgovor je zabilježen u 19% ispitanika.
English: Healthcare providers need to assess the benefit and potential risks of administering Pandemic influenza vaccine H5N1 AstraZeneca to pregnant women.
Croatian: Zdravstveni djelatnici moraju procijeniti koristi i potencijalne rizike primjene Pandemijskog cjepiva protiv influence H5N1 AstraZeneca u trudnica.
English: He or she will decide if Pandemic influenza vaccine H5N1 AstraZeneca is suitable for you.
Croatian: Oni će odlučiti je li Pandemijsko cjepivo protiv influence H5N1 AstraZeneca prikladno cjepivo za Vas.
English: Reassortant influenza virus* (live attenuated) of the following strain**:
Croatian: Presloženi virus influence* (živi, atenuirani) sljedećeg soja**:
English: After 1 or 2 doses of TCID50 vaccine, haemagglutination inhibition (HAI) and IgA seroresponses were each detected in 10% subjects, and nasal wash IgA responses were detected in 24% subjects.
Croatian: TCID50, u po 10% ispitanika zabilježeni su i inhibicija hemaglutinacije (engl. haemagglutination inhibition, HAI) i IgA serološki odgovori, dok je uzimanjem nazalnog ispirka zabilježen IgA odgovor u 24% ispitanika.
English: Improved efficacy (95% CI) all strains regardless of match
Croatian: Poboljšana djelotvornost (95% CI) svi sojevi bez obzira na podudarnost
English: Study number
Croatian: Broj ispitivanja
English: The co-administration of Pandemic influenza vaccine H5N1 AstraZeneca with inactivated vaccines or with the seasonal vaccine Fluenz Tetra has not been studied.
Croatian: Nije ispitana istodobna primjena Pandemijskog cjepiva protiv influence H5N1 AstraZeneca s inaktiviranim cjepivima ili sa sezonskim cjepivom Fluenz Tetra.
English: • Pandemic influenza vaccine H5N1 AstraZeneca is not recommended for breast-feeding women.
Croatian: • Pandemijsko cjepivo protiv influence H5N1 AstraZeneca se ne preporučuje ženama koje doje.
English: AstraZeneca A.E. Τηλ: +30 2-10 6871500
Croatian: Τηλ: +30 2-10 6871500
English: Efficacy (95% CI) all strains regardless of match
Croatian: Djelotvornost (95% CI) svi sojevi bez obzira na podudarnost
English: 11 to 24 M 1,150 2002-2003
Croatian: Europa, Azija/ Oceanija, Latinska Amerika od 11 do 24 M 1150 2002-2003
English: Reassortant influenza virus (live attenuated) of the following strain:
Croatian: Presloženi virus influence (živi, atenuirani) sljedećih četiriju sojeva:
English: If any of these apply, tell your doctor, nurse or pharmacist before vaccination.
Croatian: Ako se nešto od navedenog odnosi na Vas, obavijestite svog liječnika, medicinsku sestru ili ljekarnika prije nego primite ovo cjepivo.
English: What you need to know before you are given Pandemic influenza vaccine H5N1 AstraZeneca
Croatian: Što morate znati prije nego primite Pandemijsko cjepivo protiv influence H5N1 AstraZeneca
English: Pandemic influenza vaccine H5N1 AstraZeneca should be used in accordance with official guidance.
Croatian: Pandemijsko cjepivo protiv influence H5N1 AstraZeneca potrebno je primjenjivati u skladu sa službenim preporukama.
English: • Pandemic influenza vaccine H5N1 AstraZeneca is administered as a divided dose in both nostrils as described below.
Croatian: • Pandemijsko cjepivo protiv influence H5N1 AstraZeneca se primjenjuje kao podijeljena doza u obje nosnice, kako je dolje opisano.
English: Efficacy (95% CI) matched strains
Croatian: Djelotvornost (95% CI) podudarni sojevi
English: Other possible side effects of Pandemic influenza vaccine H5N1 AstraZeneca:
Croatian: Druge moguće nuspojave pandemijskog cjepiva protiv influence H5N1 AstraZeneca:
English: Pandemic influenza vaccine H5N1 AstraZeneca must not be injected.
Croatian: Pandemijsko cjepivo protiv influence H5N1 AstraZeneca se ne smije injicirati.
English: Pandemic influenza vaccine H5N1 AstraZeneca nasal spray, suspension Pandemic influenza vaccine (H5N1) (live attenuated, nasal)
Croatian: Pandemijsko cjepivo protiv influence H5N1 AstraZeneca, sprej za nos, suspenzija Pandemijsko cjepivo protiv influence (H5N1) (živo, atenuirano, za nos)
English: What Pandemic influenza vaccine H5N1 AstraZeneca is and what it is used for
Croatian: Što je Pandemijsko cjepivo protiv influence H5N1 AstraZeneca i za što se koristi
English: Dibasic potassium phosphate Monobasic potassium phosphate Gelatin (porcine, Type A) Arginine hydrochloride Monosodium glutamate monohydrate Water for injections
Croatian: 6.1 Popis pomoćnih tvari saharoza kalijev dihidrogenfosfat kalijev hidrogenfosfat želatina (svinjskog porijekla, tip A) argininklorid natrijev glutamat hidrat voda za injekcije
English: There are no data available on the use of Pandemic influenza vaccine H5N1 AstraZeneca in pregnant women.
Croatian: Nema dostupnih podataka o primjeni Pandemijskog cjepiva protiv influence H5N1 AstraZeneca u trudnica.
English: If you have any further questions on this vaccine, ask your doctor, nurse or pharmacist.
Croatian: U slučaju bilo kakvih pitanja u vezi s ovim cjepivom, obratite se svom liječniku, medicinskoj sestri ili ljekarniku.
English: The other ingredients are sucrose, dibasic potassium phosphate, monobasic potassium phosphate, gelatin (porcine, Type A), arginine hydrochloride, monosodium glutamate monohydrate and water for injections.
Croatian: Pomoćne tvari su: saharoza, kalijev dihidrogenfosfat, kalijev hidrogenfosfat, želatina (svinjskog porijekla, tip A), argininklorid, natrijev glutamat hidrat i voda za injekcije.
English: Excipients: sucrose, dibasic potassium phosphate, monobasic potassium phosphate, gelatin (porcine, Type A), arginine hydrochloride, monosodium glutamate monohydrate, water for injections.
Croatian: Pomoćne tvari: saharoza, kalijev dihidrogenfosfat, kalijev hidrogenfosfat, želatinu (svinjskog porijekla, tip A), argininklorid, natrijev glutamat hidrat, vodu za injekcije.
English: Do not inject Pandemic influenza vaccine H5N1 AstraZeneca.
Croatian: Nemojte injicirati Pandemijsko cjepivo protiv influence H5N1 AstraZeneca.
English: Number of study participants
Croatian: Broj ispitanika
English: The MAH should conduct an observational prospective cohort safety study in a large sample of children and adolescents from 12 months to less than 18 years of age during the next declared pandemic.
Croatian: Tijekom sljedeće objavljene pandemije, nositelj odobrenja treba provesti opservacijsko prospektivno kohortno ispitivanje sigurnosti na velikom uzorku djece i adolescenata u dobi od 12 mjeseci do manje od 18 godina.
English: Pandemic influenza vaccine H5N1 AstraZeneca will be given as a spray in each nostril.
Croatian: Pandemijsko cjepivo protiv influence H5N1 AstraZeneca se daje kao sprej u svaku nosnicu.
English: What Pandemic influenza vaccine H5N1 AstraZeneca looks like and contents of the pack
Croatian: Kako Pandemijsko cjepivo protiv influence H5N1 AstraZeneca izgleda i sadržaj pakiranja
English: General disorders and administration site conditions Very common: Malaise
Croatian: Opći poremećaji i reakcije na mjestu primjene Vrlo često: opće loše osjećanje Često: pireksija
English: Twenty-one additional subjects received one dose of the vaccine virus at TCID50, with 19 of those subjects receiving a second dose 4-8 weeks later.
Croatian: TCID50, od čega je 19 ispitanika primilo drugu dozu nakon 4 do 8 tjedana.
English: • Pandemic influenza vaccine H5N1 AstraZeneca is administered as a divided dose in both nostrils.
Croatian: • Pandemijsko cjepivo protiv influence H5N1 AstraZeneca se primjenjuje kao podijeljena doza u obje nosnice.
English: Children and adolescents under 18 years of age receiving salicylate therapy should avoid vaccination with Pandemic influenza vaccine H5N1 AstraZeneca (see section 4.4).
Croatian: Cijepljenje Pandemijskim cjepivom protiv influence H5N1 AstraZeneca u djece i adolescenata mlađih od 18 godina koji primaju terapiju salicilatima treba se izbjegavati (vidjeti dio 4.4).
English: It is not known whether Pandemic influenza vaccine H5N1 AstraZeneca is excreted in human milk.
Croatian: Nije poznato izlučuje li se Pandemijsko cjepivo protiv influence H5N1 AstraZeneca u majčino mlijeko.
English: Pandemic influenza vaccine H5N1 AstraZeneca is administered as a divided dose in both nostrils.
Croatian: Pandemijsko cjepivo protiv influence H5N1 AstraZeneca se primjenjuje kao podijeljena doza u obje nosnice.
English: In clinical study CIR 239, the safety, infectivity, and immunogenicity of a live attenuated vaccine derived from A/Hong Kong/213/2003 (H5N1) influenza isolate were evaluated in 17 subjects who received one dose of 10
Croatian: U kliničkom ispitivanju CIR 239 procijenjeni su sigurnost, infektivnost i imunogenost živog atenuiranog cjepiva proizvedenog iz izolata virusa influence A/Hong Kong/213/2003 (H5N1) na 17 ispitanika koji su u uvjetima izolacije primili intranazalno jednu dozu virusnog cjepiva od 10 TCID50, od kojih je 16 ispitanika primilo drugu dozu nakon 4 do 8 tjedana.
English: You should not be given Pandemic influenza vaccine H5N1 AstraZeneca:
Croatian: Nemojte primiti pandemijsko cjepivo protiv influence H5N1 AstraZeneca:
English: Pandemic influenza vaccine H5N1 AstraZeneca must only be used as a nasal spray.
Croatian: Pandemijsko cjepivo protiv influence H5N1 AstraZeneca se smije koristiti samo kao sprej za nos.
English: Figure 1 Pandemic influenza vaccine H5N1 AstraZeneca Administration
Croatian: Slika 1 Primjena Pandemijskog cjepiva protiv influence H5N1 AstraZeneca
English: What Pandemic influenza vaccine H5N1 AstraZeneca contains
Croatian: Što Pandemijsko cjepivo protiv influence H5N1 AstraZeneca sadrži
English: Position the applicator With the patient in an upright position, place the tip just inside the nostril to ensure Pandemic influenza vaccine H5N1
Croatian: Postavite vrh malo unutar nosnice kako biste osigurali da pandemijsko cjepivo protiv influence H5N1 AstraZeneca bude uštrcano u nos.
English: IgA seroresponse and nasal wash response were each detected in 18% of subjects.
Croatian: U 18% ispitanika zabilježen je IgA odgovor i serološki i u nazalnom ispirku
English: Asia/ Oceania
Croatian: Azija/ Oceanija od 12 do 35 M
English: How to store Pandemic influenza vaccine H5N1 AstraZeneca
Croatian: Kako čuvati Pandemijsko cjepivo protiv influence H5N1 AstraZeneca
English: None
Croatian: a
English: Africa, Latin America
Croatian: Afrika, Latinska Amerika od 6 do 35 M
English: Pandemic influenza vaccine H5N1 AstraZeneca is for nasal use only.
Croatian: Pandemijsko cjepivo protiv influence H5N1 AstraZeneca je namijenjeno samo za primjenu za nos.
English: Pandemic influenza vaccine H5N1 AstraZeneca IS FOR NASAL USE ONLY.
Croatian: Pandemijsko cjepivo protiv influence H5N1 AstraZeneca JE NAMIJENJENO SAMO ZA PRIMJENU ZA NOS.
English: Peak incidence of vaccine virus recovery occurred 1-2 days post-vaccination in clinical studies with Pandemic influenza vaccine H5N1 AstraZeneca.
Croatian: U kliničkim ispitivanjima Pandemijskog cjepiva protiv influence H5N1 AstraZeneca, vršna prisutnost virusa cjepiva javila se 1 do 2 dana nakon cijepljenja.
English: How Pandemic influenza vaccine H5N1 AstraZeneca works
Croatian: Pandemijsko cjepivo protiv influence H5N1 AstraZeneca
English: B. PACKAGE LEAFLET
Croatian: Popis nuspojava
English: How Pandemic influenza vaccine H5N1 AstraZeneca is given
Croatian: Kako se primjenjuje Pandemijsko cjepivo protiv influence H5N1 AstraZeneca
English: 112 (4 x 28) tablets (multipack)
Croatian: 112 (4 x 28) tableta (višestruko pakiranje)
English: Invented name Strength Pharmaceutical Form
Croatian: (Zaštićeno) ime Doza Farmaceutski oblik Put primjene
English: 0.6 ml (10 mg/ml) 1 pre-filled syringe + on body injector (Onpro kit)
Croatian: 1 napunjena štrcaljka + on-body injektor (Onpro pribor)
English: Solution for injection Subcutaneous use Pre-filled syringe (glass) with on body-injector (Onpro kit)
Croatian: napunjena štrcaljka (staklena) s on-body injektorom (Onpro pribor)
English: Solution for injection Subcutaneous use pre-filled syringe (glass) with needle guard
Croatian: 1 napunjena štrcaljka sa automatskim štitnikom za iglu (u blisteru)
English: Solution for injection Subcutaneous use pre-filled syringe (glass)
Croatian: napunjena štrcaljka (staklena)
English: 1 bottle + 1 dosing syringe + 1 adapter
Croatian: 1 bočica + 1 dozirna štrcaljka + 1 nastavak
English: Blister (PVC/alu foil)
Croatian: Filmom obložene tablete blister (PVDC/alu)
English: Bottle (HDPE)
Croatian: (HDPE)
English: (Invented) name Strength Pharmaceutical form
Croatian: Farmaceutski oblik Način primjene
English: 20mg/mL Oral solution Oral use
Croatian: 20 mg/ml
English: Film-coated tablet
Croatian: Oralna otopina bočica
English: Risk Management Plan (RMP)
Croatian: · Plan upravljanja rizikom (RMP)
English: • Fever: if you have a temperature of 38°C or greater.
Croatian: • vrućica: ako imate temperaturu od 38°C ili višu.
English: Take the tablets morning and evening as prescribed by your doctor.
Croatian: • Tablete uzimajte ujutro i navečer, kako Vam je propisao liječnik.
English: (neuropathy)
Croatian: (neuropatiju))
English: PVC/PVDC blisters
Croatian: PVC/PVDC blisteri
English: • if you have a history of eye problems as you may need extra monitoring of your eyes
Croatian: • ako ste ranije imali očnih tegoba jer će vam možda biti potrebna dodatna kontrola očiju
English: You must not take Xeloda if you are pregnant or think you might be.
Croatian: Ne smijete uzimati lijek Xeloda ako ste trudni ili mislite da biste mogli biti trudni.
English: You must inform your doctor if you know that you have an allergy or over-reaction to this medicine,
Croatian: Morate obavijestiti svog liječnika ako znate da ste alergični ili preosjetljivi na ovaj lijek,
English: STOP taking Xeloda immediately and contact your doctor if any of these symptoms occur:
Croatian: PRESTANITE odmah uzimati lijek Xeloda i obratite se liječniku ako se pojave neki od ovih simptoma:
English: UNIQUE IDENTIFIER - 2D BARCODE <2D barcode carrying the unique identifier included.>
Croatian: 17. JEDINSTVENI IDENTIFIKATOR - 2D BARKOD Sadrži 2D barkod s jedinstvenim identifikatorom.
English: • if you cannot keep food or water in your body because of severe nausea and vomiting
Croatian: • ako ne možete zadržati hranu ili vodu u vašem tijelu uslijed jake mučnine ili povraćanja
English: Take the tablets within 30 minutes after the end of a meal (breakfast and dinner) and swallow whole with water.
Croatian: • Tablete uzimajte najkasnije 30 minuta nakon što završite s jelom (doručkom i večerom) i progutajte ih cijele, s vodom.
English: About 3% of the administered dose is excreted in urine unchanged
Croatian: Oko 3% primijenjene doze izluči urinom u nepromijenjenom obliku.
English: See also section “Do not take Xeloda”.
Croatian: Pogledajte i dio „Nemojte uzimati lijek Xeloda“.
English: Xeloda tablets should not be crushed or cut.
Croatian: Xeloda tablete ne smiju se drobiti ni lomiti.
English: What Xeloda is and what it is used for
Croatian: Što je Xeloda i za što se koristi
English: Xeloda may be used either alone or in combination with other medicines.
Croatian: Xeloda se može primijeniti samostalno ili u kombinaciji s drugim lijekovima.
English: Dose adjustment for next cycle/dose (% of starting dose)
Croatian: Prilagodba doze u sljedećem ciklusu/dozi (% početne doze)
English: Xeloda tablets are usually taken for 14 days followed by a 7 day rest period (when no tablets are taken).
Croatian: Xeloda tablete se uobičajeno uzimaju 14 dana, nakon čega slijedi 7 dana pauze (bez uzimanja tableta).
English: Other medicines and Xeloda
Croatian: Drugi lijekovi i Xeloda
English: If you cannot swallow Xeloda tablets whole, tell your healthcare provider.
Croatian: Ako Xeloda tablete ne možete progutati cijele, obavijestite o tome svog zdravstvenog radnika.
English: If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Croatian: Ako ste trudni ili dojite, mislite da bi mogli biti trudni ili planirate imati dijete, obratite se svom liječniku ili ljekarniku za savjet prije nego uzmete ovaj lijek.
English: In addition to the above, when Xeloda is used alone, very common side effects, which may affect more than 1 in 10 people are:
Croatian: Uz prethodno navedene, kada se Xeloda primjenjuje samostalno, vrlo česte nuspojave koje se mogu javiti u više od 1 na 10 osoba su:
English: • if you have brain diseases (for example, cancer that has spread to the brain, or nerve damage
Croatian: • ako imate bolest mozga (primjerice rak koji se proširio u mozak ili oštećenje živaca
English: Do not give Xeloda to children and adolescents.
Croatian: Nemojte davati lijek Xeloda djeci i adolescentima.
English: Your doctor may instruct you to decrease the dose and/or temporarily discontinue treatment with Xeloda.
Croatian: Liječnik Vam može savjetovati da smanjite dozu i/ili privremeno prestanete uzimati lijek Xeloda.
English: If you take more Xeloda than you should, contact your doctor as soon as possible before taking the next dose.
Croatian: Ako uzmete više Xeloda tableta nego što ste trebali, što prije se obratite svom liječniku prije uzimanja sljedeće doze.
English: What Xeloda looks like and contents of the pack
Croatian: Kako Xeloda izgleda i sadržaj pakiranja
English: Severe and/or Lifethreatening (grade 3-4) or considered medically relevant
Croatian: Teške i/ili po život opasne (stupanj 3 do 4) ili one koje se smatraju medicinski značajnima
English: Table 3 Capecitabine dose reduction schedule (3 weekly cycle or continuous treatment) Toxicity grades*
Croatian: Tablica 3 Raspored smanjivanja doze kapecitabina (ciklusi od 3 tjedna ili kontinuirano liječenje) Stupanj toksičnosti*
English: Talk to your doctor or pharmacist before taking Xeloda
Croatian: Obratite se svom liječniku ili ljekarniku prije nego uzmete lijek Xeloda:
English: Furthermore, Xeloda is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery.
Croatian: Nadalje, Xeloda se koristi za sprječavanje pojave novog karcinoma kolona nakon što je tumor u potpunosti kirurški uklonjen.
English: • Grade 1
Croatian: · Stupanj 1
English: Finally, β-ureido-propionase cleaves FUPA to α-fluoro-βalanine (FBAL) which is cleared in the urine.
Croatian: Na kraju, β-ureido-propionaza cijepa FUPA do α-fluoro-β alanina (FBAL) koji se izlučuje urinom.
English: Pharmacotherapeutic group: cytostatic (antimetabolite), ATC code: L01BC06
Croatian: Farmakoterapijska skupina: citostatik (antimetabolit), ATK oznaka: L01BC06
English: If you take more Xeloda than you should
Croatian: Ako uzmete više Xeloda tableta nego što ste trebali
English: • if you previously have had severe reactions to fluoropyrimidine therapy (a group of anticancer medicines such as fluorouracil),
Croatian: • ako ste prethodno imali tešku reakciju na liječenje fluoropirimidinima (skupina lijekova protiv raka poput fluorouracila),